Showing results (201-210 of 477) with videos related to
Sort By:
Pageof 48
Circulation|May 1, 2004
Thrombocytopenia caused by abciximab or tirofiban and its association with clinical outcome in patients undergoing coronary stentingPiera Angelica Merlini, Marco Rossi, Alberto Menozzi, et al.The American Journal of Cardiology|April 13, 2002
Evidence that angiotensin-converting enzyme inhibitor use diminishes the need for coronary revascularization after stentingStephen G Ellis, A Michael Lincoff, Patrick L Whitlow, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 28, 2002
Reduction in vascular access site bleeding in sequential abciximab coronary intervention trialsJames C Blankenship, Craig Balog, Shelly K Sapp, et al.Journal of the American College of Cardiology|September 3, 2002
Mortality benefit of beta-blockade after successful elective percutaneous coronary interventionAlbert W Chan, Martin J Quinn, Deepak L Bhatt, et al.NPJ Digital Medicine|April 20, 2022
Inter-individual variation in objective measure of reactogenicity following COVID-19 vaccination via smartwatches and fitness bandsGiorgio Quer, Matteo Gadaleta, Jennifer M Radin, et al.Medrxiv : the Preprint Server for Health Sciences|May 11, 2021
The Physiologic Response to COVID-19 VaccinationGiorgio Quer, Matteo Gadaleta, Jennifer M Radin, et al.Journal of the American College of Cardiology|October 2, 2002
Patient outcomes after fibrinolytic therapy for acute myocardial infarction at hospitals with and without coronary revascularization capabilityRajendra H Mehta, Douglas A Criger, Christopher B Granger, et al.NPJ Digital Medicine|July 16, 2019
The Healthy Pregnancy Research Program: transforming pregnancy research through a ResearchKit appJennifer M Radin, Steven R Steinhubl, Andrew I Su, et al.Physical Biology|January 11, 2014
Fluid phase biopsy for detection and characterization of circulating endothelial cells in myocardial infarctionKelly Bethel, Madelyn S Luttgen, Samir Damani, et al.American Heart Journal|April 1, 2009
Ethnic variation in adverse cardiovascular outcomes and bleeding complications in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) studyKoon-Hou Mak, Deepak L Bhatt, Mingyuan Shao, et al.Pageof 48